StockWatch
·
Other Pharmaceuticals
InvestmentMay 29, 2026, 05:32 PM

Wellgistics Health Raises $16.9M via Convertible Notes & Warrants

AI Summary

Wellgistics Health, Inc. secured $16,906,250 in new funding through a Securities Purchase Agreement, issuing convertible promissory notes with an aggregate principal amount of $21,132,812.50 and warrants to accredited investors. The notes bear 0% interest, mature in 12 months, and are convertible into common stock or Series A Preferred Stock. Additionally, holders of a majority of the company's common shares, totaling 1,333,930 shares, entered into a 90-day lock-up agreement, demonstrating shareholder confidence in the company's growth strategy.

Key Highlights

  • Wellgistics Health raised $16,906,250 in cash from accredited investors.
  • Issued convertible promissory notes with a $21,132,812.50 aggregate principal amount.
  • Notes were issued at a 20% original issue discount.
  • Notes mature in 12 months and bear 0% interest.
  • Convertible into common stock at $6.00/share or market price (initial floor $1.00).
  • Mandatory conversion into Series A Preferred Stock with 10% annual dividends.
  • Holders of 1,333,930 common shares agreed to a 90-day lock-up.
  • Company will seek stockholder approval for issuances exceeding 19.99% exchange cap.